Evidence map›Paper›PMID 20490958›Full record

ArticleAAPS PharmSciTech2010

Characterization of polymeric solutions as injectable vehicles for hydroxyapatite microspheres.

Serafim M Oliveira, Isabel F Almeida, Paulo C Costa, Cristina C Barrias, M Rosa Pena Ferreira, M Fernanda Bahia, Mário A Barbosa

Abstract read
In one paragraph

Article in AAPS PharmSciTech, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Serafim M OliveiraDep. de Eng. Mecânica e Gestão Industrial, Escola Superior de Tecnologia e Gestão de Viseu, Campus Politécnico de Repeses, 3504-510, Viseu, Portugal. soliveira@estv.ipv.pt
Isabel F Almeida
Paulo C Costa
Cristina C Barrias
M Rosa Pena Ferreira
M Fernanda Bahia
Mário A Barbosa

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A polymeric solution and a reinforcement phase can work as an injectable material to fill up bone defects. However, the properties of the solution should be suitable to enable the transport of that extra phase. Additionally, the use of biocompatible materials is a requirement for tissue regeneration. Thus, we intended to optimize a biocompatible polymeric solution able to carry hydroxyapatite microspheres into bone defects using an orthopedic injectable device. To achieve that goal, polymers usually regarded as biocompatible were selected, namely sodium carboxymethylcellulose, hydroxypropylmethylcellulose, and Na-alginate (ALG). The rheological properties of the polymeric solutions at different concentrations were assessed by viscosimetry before and after moist heat sterilization. In order to correlate rheological properties with injectability, solutions were tested using an orthopedic device applied for minimal invasive surgeries. Among the three polymers, ALG solutions presented the most suitable properties for our goal and a non-sterile ALG 6% solution was successfully used to perform preliminary injection tests of hydroxyapatite microspheres. Sterile ALG 7.25% solution was found to closely match non-sterile ALG 6% properties and it was selected as the optimal vehicle. Finally, sterile ALG 7.25% physical stability was studied at different temperatures over a 3-month period. It was observed that its rheological properties presented minor changes when stored at 25 degrees C or at 4 degrees C.

Indexed as

CapsulesBiocompatible MaterialsDrug CompoundingDurapatiteExcipientsInjectionsPharmaceutical VehiclesPolymersSolutionsBiocompatible MaterialsCapsulesDurapatiteExcipientsPharmaceutical VehiclesPolymersSolutions

Identifiers

PMID20490958
PMCPMC2902341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.